EFL

Role: Mentor

Tracks: Life Sciences

Muredach Reilly

Vice Dean for Clinical and Translational Research, Director of the Irving Institute | Columbia University Medical Center

Dr. Reilly serves as Director of the Irving Institute for Clinical and Translational Research. He is also the Vice Dean for Clinical and Translational Research at the Vagelos College of Physicians and Surgeons at Columbia University Irving Medical Center and Director of the Cardiometabolic Precision Medicine Program in the Division of Cardiology. Dr. Reilly, a cardiologist leads a research program dedicated to precision medicine studies of cardiovascular disease and related metabolic disorders. Clinically, he is an expert in preventive cardiology and provides expert care for patients with rare cholesterol disorders and premature heart disease. His genomics and translational research emphasizes humans as the most ideal “model” to understand mechanisms of human disease and therapeutic opportunities for prevention. He has been continuously funded by the NIH and other agencies for over 20 years, has published over 300 peer-reviewed original research papers, and has mentored dozens of trainees to pursue careers in academia and industry. In his leadership positions at Columbia, he has been responsible for launching with Columbia Tech Ventures the Translational Therapeutics Accelerator program and expanding the Lab-to-Market life-science accelerators. Prior to his role at Columbia, Dr. Reilly held faculty positions at UPenn and led initiatives in cardiovascular genomics and in clinical and translational research. Dr. Reilly received his medical degree from University College Dublin, Ireland and completed his residency and fellowship training in Medicine and Cardiovascular Medicine at the University of Pennsylvania, where he also received an M.S. degree in clinical epidemiology. In 2010, Dr. Reilly was elected to the Royal College of Physicians in Ireland as well as to the American Society of Clinical Investigation. In addition, he has received numerous awards, including the 2006 UPenn Donald B. Martin Teaching Service Award, the 2013 William Osler Patient Oriented Research Award, American Heart Association’s Mentor of Women Award in 2015 and, in 2018, the Jeffrey M. Hoeg Award for Basic Science and Clinical Research from Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB). He is also a member of the Association of American Physicians.